Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Current management of patients with congenital heart disease has increased their survival into adulthood. This is accompanied by potential cardiac complications, including pulmonary hypertension associated with congenital heart disease (PAH-CHD). PAH-CHD constitutes a challenging subgroup of pulmona...

Full description

Bibliographic Details
Main Authors: Ahmed K. Mahmoud, Mohammed Tiseer Abbas, Moaz A. Kamel, Juan M. Farina, Milagros Pereyra, Isabel G. Scalia, Timothy Barry, Chieh-Ju Chao, Francois Marcotte, Chadi Ayoub, Robert L. Scott, David S. Majdalany, Reza Arsanjani
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Personalized Medicine
Subjects:
pulmonary hypertension
congenital heart disease
sildenafil
bosentan
macitentan
epoprostenol
Online Access:https://www.mdpi.com/2075-4426/14/1/5

Internet

https://www.mdpi.com/2075-4426/14/1/5

Similar Items